vs
Side-by-side financial comparison of AbbVie (ABBV) and Coca-Cola Company (The) (KO). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $11.8B, roughly 1.4× Coca-Cola Company (The)). Coca-Cola Company (The) runs the higher net margin — 19.2% vs 10.9%, a 8.3% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs 2.4%). AbbVie produced more free cash flow last quarter ($4.9B vs $2.9B). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 2.3%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The Coca-Cola Company is an American multinational corporation founded in 1892 headquartered in Atlanta, Georgia. It manufactures, sells and markets soft drinks including Coca-Cola, other non-alcoholic beverage concentrates and syrups, and alcoholic beverages. Its stock is listed on the New York Stock Exchange and is a component of the DJIA and the S&P 500 and S&P 100 indices.
ABBV vs KO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $11.8B |
| Net Profit | $1.8B | $2.3B |
| Gross Margin | 72.6% | 60.0% |
| Operating Margin | 27.3% | 15.6% |
| Net Margin | 10.9% | 19.2% |
| Revenue YoY | 10.0% | 2.4% |
| Net Profit YoY | 8354.5% | 3.5% |
| EPS (diluted) | $1.02 | $0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | $11.8B | ||
| Q3 25 | $15.8B | $12.5B | ||
| Q2 25 | $15.4B | $12.5B | ||
| Q1 25 | $13.3B | $11.1B | ||
| Q4 24 | $15.1B | $11.5B | ||
| Q3 24 | $14.5B | $11.9B | ||
| Q2 24 | $14.5B | $12.4B | ||
| Q1 24 | $12.3B | $11.3B |
| Q4 25 | $1.8B | $2.3B | ||
| Q3 25 | $186.0M | $3.7B | ||
| Q2 25 | $938.0M | $3.8B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $-22.0M | $2.2B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.4B | $2.4B | ||
| Q1 24 | $1.4B | $3.2B |
| Q4 25 | 72.6% | 60.0% | ||
| Q3 25 | 66.4% | 61.5% | ||
| Q2 25 | 71.8% | 62.4% | ||
| Q1 25 | 70.0% | 62.6% | ||
| Q4 24 | 70.9% | 60.0% | ||
| Q3 24 | 70.9% | 60.7% | ||
| Q2 24 | 70.9% | 61.1% | ||
| Q1 24 | 66.7% | 62.5% |
| Q4 25 | 27.3% | 15.6% | ||
| Q3 25 | 12.1% | 32.0% | ||
| Q2 25 | 31.7% | 34.1% | ||
| Q1 25 | 28.0% | 32.9% | ||
| Q4 24 | -9.9% | 23.5% | ||
| Q3 24 | 26.5% | 21.2% | ||
| Q2 24 | 27.6% | 21.3% | ||
| Q1 24 | 22.7% | 18.9% |
| Q4 25 | 10.9% | 19.2% | ||
| Q3 25 | 1.2% | 29.7% | ||
| Q2 25 | 6.1% | 30.4% | ||
| Q1 25 | 9.6% | 29.9% | ||
| Q4 24 | -0.1% | 19.0% | ||
| Q3 24 | 10.8% | 24.0% | ||
| Q2 24 | 9.5% | 19.5% | ||
| Q1 24 | 11.1% | 28.1% |
| Q4 25 | $1.02 | $0.53 | ||
| Q3 25 | $0.10 | $0.86 | ||
| Q2 25 | $0.52 | $0.88 | ||
| Q1 25 | $0.72 | $0.77 | ||
| Q4 24 | $-0.03 | $0.50 | ||
| Q3 24 | $0.88 | $0.66 | ||
| Q2 24 | $0.77 | $0.56 | ||
| Q1 24 | $0.77 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | $10.3B |
| Total DebtLower is stronger | $58.9B | $42.1B |
| Stockholders' EquityBook value | $-3.3B | $32.2B |
| Total Assets | $134.0B | $104.8B |
| Debt / EquityLower = less leverage | — | 1.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | $10.3B | ||
| Q3 25 | $5.7B | $12.7B | ||
| Q2 25 | $6.5B | $9.6B | ||
| Q1 25 | $5.2B | $8.4B | ||
| Q4 24 | $5.6B | $10.8B | ||
| Q3 24 | $7.3B | $13.9B | ||
| Q2 24 | $13.2B | $13.7B | ||
| Q1 24 | $18.1B | $10.4B |
| Q4 25 | $58.9B | $42.1B | ||
| Q3 25 | $63.0B | $43.2B | ||
| Q2 25 | $63.0B | $45.0B | ||
| Q1 25 | $64.5B | $43.5B | ||
| Q4 24 | $60.3B | $42.4B | ||
| Q3 24 | $58.5B | $43.0B | ||
| Q2 24 | $58.0B | $38.1B | ||
| Q1 24 | $63.8B | $36.5B |
| Q4 25 | $-3.3B | $32.2B | ||
| Q3 25 | $-2.6B | $31.2B | ||
| Q2 25 | $-183.0M | $28.6B | ||
| Q1 25 | $1.4B | $26.2B | ||
| Q4 24 | $3.3B | $24.9B | ||
| Q3 24 | $6.0B | $26.5B | ||
| Q2 24 | $6.8B | $25.9B | ||
| Q1 24 | $8.0B | $26.4B |
| Q4 25 | $134.0B | $104.8B | ||
| Q3 25 | $133.9B | $106.0B | ||
| Q2 25 | $137.2B | $104.3B | ||
| Q1 25 | $136.2B | $101.7B | ||
| Q4 24 | $135.2B | $100.5B | ||
| Q3 24 | $143.4B | $106.3B | ||
| Q2 24 | $141.9B | $101.2B | ||
| Q1 24 | $148.9B | $99.4B |
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.38× | ||
| Q2 25 | — | 1.57× | ||
| Q1 25 | 45.44× | 1.66× | ||
| Q4 24 | 18.15× | 1.70× | ||
| Q3 24 | 9.70× | 1.62× | ||
| Q2 24 | 8.56× | 1.47× | ||
| Q1 24 | 7.97× | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $3.8B |
| Free Cash FlowOCF − Capex | $4.9B | $2.9B |
| FCF MarginFCF / Revenue | 29.4% | 24.3% |
| Capex IntensityCapex / Revenue | 2.0% | 7.5% |
| Cash ConversionOCF / Net Profit | 2.87× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $5.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | $3.8B | ||
| Q3 25 | $7.0B | $5.0B | ||
| Q2 25 | $5.2B | $3.8B | ||
| Q1 25 | $1.6B | $-5.2B | ||
| Q4 24 | $7.0B | $4.0B | ||
| Q3 24 | $5.4B | $-1.3B | ||
| Q2 24 | $2.3B | $3.6B | ||
| Q1 24 | $4.0B | $528.0M |
| Q4 25 | $4.9B | $2.9B | ||
| Q3 25 | $6.6B | $4.6B | ||
| Q2 25 | $4.9B | $3.4B | ||
| Q1 25 | $1.4B | $-5.5B | ||
| Q4 24 | $6.8B | $3.1B | ||
| Q3 24 | $5.2B | $-1.7B | ||
| Q2 24 | $2.0B | $3.2B | ||
| Q1 24 | $3.8B | $158.0M |
| Q4 25 | 29.4% | 24.3% | ||
| Q3 25 | 42.1% | 36.6% | ||
| Q2 25 | 31.7% | 26.9% | ||
| Q1 25 | 10.5% | -49.5% | ||
| Q4 24 | 44.7% | 27.3% | ||
| Q3 24 | 35.9% | -14.6% | ||
| Q2 24 | 14.0% | 25.6% | ||
| Q1 24 | 31.3% | 1.4% |
| Q4 25 | 2.0% | 7.5% | ||
| Q3 25 | 2.4% | 3.8% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 1.8% | 2.8% | ||
| Q4 24 | 1.9% | 7.0% | ||
| Q3 24 | 1.7% | 4.0% | ||
| Q2 24 | 1.7% | 3.4% | ||
| Q1 24 | 1.6% | 3.3% |
| Q4 25 | 2.87× | 1.65× | ||
| Q3 25 | 37.76× | 1.36× | ||
| Q2 25 | 5.49× | 1.00× | ||
| Q1 25 | 1.27× | -1.56× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | 3.49× | -0.44× | ||
| Q2 24 | 1.66× | 1.49× | ||
| Q1 24 | 2.95× | 0.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
KO
| Other | $7.0B | 59% |
| Finished Product Operations | $2.4B | 21% |
| Concentrate Operations | $2.4B | 20% |
